Investigative Ophthalmology & Visual Science Cover Image for Volume 62, Issue 8
June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Retinal Vascular Physiology Biomarkers in a 5XFAD Mouse Model of Alzheimer’s Disease
Author Affiliations & Notes
  • Nathanael Matei
    Ophthalmology, University of Southern California, Los Angeles, California, United States
  • Sophie Leahy
    Ophthalmology, University of Southern California, Los Angeles, California, United States
  • Norman P Blair
    Ophthalmology, University of Illinois at Chicago, Chicago, Illinois, United States
  • James Burford
    Ophthalmology, University of Southern California, Los Angeles, California, United States
  • Mahnaz Shahidi
    Ophthalmology, University of Southern California, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Nathanael Matei, None; Sophie Leahy, None; Norman Blair, None; James Burford, None; Mahnaz Shahidi, USC (P)
  • Footnotes
    Support  EY017918, EY029220
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 356. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nathanael Matei, Sophie Leahy, Norman P Blair, James Burford, Mahnaz Shahidi; Retinal Vascular Physiology Biomarkers in a 5XFAD Mouse Model of Alzheimer’s Disease. Invest. Ophthalmol. Vis. Sci. 2021;62(8):356.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Alzheimer’s disease (AD) is a neurodegenerative disorder that lacks biomarkers for early diagnosis. The retina displays many characteristics of the AD brain, such as accumulation of amyloid beta (Aβ) oligomers and loss of function. In AD patients, changes in retinal venous velocity (V) and vascular oxygen saturation have been reported. These parameters as well as retinal oxygen metabolism (MO2) and delivery (DO2) have not been investigated in animal models of AD. The purpose of the study was to test the hypothesis that alterations in retinal arterial and venous diameter (DA, DV), V, and total retinal blood flow (TRBF), coupled with MO2 and DO2 are present in the five-familial AD (5xFAD) mice.

Methods : A total of 16 5xFAD and 16 wildtype (WT) mice were evaluated (age: 3 months). DA and DV were measured from retinal images, and V was determined by fluorescence microsphere imaging to calculate TRBF. Phosphorescence lifetime images were analyzed to derive arterial and venous oxygen contents (O2A, O2V) and arteriovenous oxygen content difference (O2AV). MO2 and DO2 were calculated from TRBF, O2A and O2AV. Data were available in 13 of 16 mice in each group. Retina and brain tissues were evaluated by ELISA assays to determine Aβ42 levels in WT (N=4) and 5xFAD mice (N=6).

Results : In the WT group, DA, DV, V, and TRBF were 27±2 μm, 30±3 μm, 11.1±3.2 mm/s, and 1.73±0.52 μl/min, respectively. In the 5xFAD group, Dv (33±3 μm) was increased, while V (7.1±1.4 mm/s) was reduced (P≤0.04). No significant differences were detected in DA and TRBF (P≥0.3). O2A, O2V, and O2AV were 6.5±1.4 mLO2/dL, 2.8±1.9 mLO2/dL, and 3.7±1.3 mLO2/dL in the WT group, respectively. In the 5xFAD group, O2A (7.8±1.2 mLO2/dL) and O2V (4.3±1.6mLO2/dL) were increased (P≤0.04), while no significant differences were detected in O2AV (P=0.8). In the WT group, MO2 and DO2 were 57±16 nLO2/min and 107±39 nLO2/min, respectively. No differences were detected in MO2 and DO2 in the 5xFAD group (P≥0.1). Retinal Aβ42 was 2.4±0.8 pg/mg in the WT group and was increased in the 5xFAD group (5.9±2.9 pg/mg; P=0.04). In the WT group, brain Aβ42 was 1.5±0.5 pg/mg and was increased in the 5xFAD group (5.4±1.3 pg/mg; P=0.0005).

Conclusions : Taken together, retinal DV, O2A, and O2V were increased, while V was decreased, whereas MO2 and DO2 were not altered in 5xFAD mice with elevated levels of Aβ42 protein in the retina and brain.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×